<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02316132</url>
  </required_header>
  <id_info>
    <org_study_id>IBS stress</org_study_id>
    <nct_id>NCT02316132</nct_id>
  </id_info>
  <brief_title>Confocal Laser Endomicroscopy, IBS and Stress</brief_title>
  <official_title>Confocal Endomicroscopy for the Detection of Food Intolerances in Patients With IBS: Add on Control Group: Does Stress Cause Similar Mucosal Changes to Food Antigens?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After standard endomicroscopy with fluorescein to investigate for dysplasia in Barrett's
      esophagus the endoscope will be forwarded into the 2nd part of the duodenum. Fluorescein is
      needed for CLE but is not part of the investigation.

      Initial CLE baseline images will be taken to assure intact mucosa and allow later detailed
      baseline counts of intraepithelial lymphocytes (IEL) and epithelial breaks in the duodenal
      mucosa.

      Thereafter, either 10 ml NaCl 0.9% or 100Âµg CRF topped up to 10ml with NaCL 0.9% (according
      to randomisation) will be injected intravenously. Endoscopist and assistant staff will be
      blinded to the randomisation. Subsequently, the gut surface will be examined for at least 5
      min with endomicroscopy for any change in IEL, epithelial breaks/gaps with extrusion of
      fluorescein into the gut lumen and widening of intervillous space.

      Post procedure mucosal fluid will be aspirated for assessment of mast cell tryptase and eosin
      catatonic protein (ECP), and 8 duodenal biopsies will be taken for 1) electron microscopy to
      visualise mast cell degranulation and 2) paraffin embedding for subsequent staining for mast
      cell tryptase to identify mast cell activation and numbers.

      The procedure will take around 15 minutes in addition to the routine investigation performed
      prior to the study. A study outline is presented in figure 1.

      Samples taken are the same amount as done in the previous food associated study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visible marked increase of leaks/gaps with extrusion of fluorescein into the gut lumen.</measure>
    <time_frame>immediate</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Stress</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of corticotropin releasing factor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Injection of 0.9% saline 10 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stress</intervention_name>
    <description>Corticotropin-Releasing Hormone</description>
    <arm_group_label>Stress</arm_group_label>
    <other_name>CRH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Saline 0.9%</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  No abdominal symptoms such as bloating and abdominal pain

          -  Barrett`s esophagus

          -  Independent indication for confocal laser endomicroscopy for evaluation of Barrett`s
             dysplasia

          -  Written informed consent for participation in this study

        Exclusion Criteria:

          -  Any known other gastrointestinal disease including infection such as helicobacter
             pylori, Morbus Whipple or others, celiac disease, or chronic inflammatory bowel
             disease

          -  Active or recent GI Bleeding

          -  Stricture in the upper gastrointestinal tract

          -  Impaired renal function (Creatinine &gt;1.2 mg/dL)

          -  Pregnancy or breast feeding

          -  Inability to obtain informed consent

          -  Known allergy to Methylene blue or Fluorescein

          -  Participation in other clinical trials within the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Ellrichmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
    <phone>00494315972075</phone>
    <email>fri.rav@btopenworld.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark Ellrichmann, MD</last_name>
    <phone>00494315972075</phone>
    <email>mark.ellrichmann@uksh.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Ellrichmann, MD</last_name>
      <phone>+494315972075</phone>
      <email>mark.ellrichmann@uk-sh.de</email>
    </contact>
    <contact_backup>
      <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
      <phone>+494315972075</phone>
      <email>fri.rav@btopenworld.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Ellrichmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>December 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2014</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Mark Ellrichmann</investigator_full_name>
    <investigator_title>Senior Consultant, Unit of Experimental Endoscopy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

